TransMedics Group Faces Class Action Lawsuit for Securities Fraud

A class action securities lawsuit has been filed against TransMedics Group, Inc. on behalf of investors who suffered losses between February 28, 2023, and January 10, 2025, due to alleged securities fraud. The lawsuit claims that TransMedics engaged in unethical practices, including using kickbacks and fraudulent billing while concealing safety issues related to its products. Notable revelations about the company’s misconduct were made public following a letter from U.S. Representative Paul Gosar in February 2024 and a report from Scorpion Capital in January 2025, which led to significant drops in the company's stock price. Investors have until April 15, 2025, to request to be appointed as lead plaintiff in this lawsuit, with no associated costs for participating. Multiple law firms, including Levi & Korsinsky and Scott+Scott, are advising affected shareholders on their rights and options. The outcome of this case could have significant implications for TransMedics and its stakeholders.